The Impact of Illicit Use of Amphetamine on Male Sexual Functions

Journal of Sexual Medicine

Volumn 12, Issue 8, 2015, Pages 1694-1702

  Chou, Nan Hua ^a   Huang, Yung Jui ^b   Jiann, Bang Ping ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b SHU TE UNIVERSITY   (Taiwan)

Author keywords

Amphetamine; Ejaculatory Latency Time; Erectile Dysfunction; Methamphetamine; Orgasmic Intensity; Sexual Desire; Sexual Satisfaction; Substance Abuse

Indexed keywords

AMPHETAMINE; APHRODISIAC AGENT; STREET DRUG;

ADULT; ALCOHOLISM; ARTICLE; CASE CONTROL STUDY; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; DOSING FREQUENCY; DRUG USE; DRUG USE DURATION; ENHANCED ORGASMIC INTENSITY; ERECTILE DYSFUNCTION; ERECTILE RIGIDITY; HIGH RISK POPULATION; HUMAN; ILLICIT DRUG USE; INTERNATIONAL INDEX OF ERECTILE FUNCTION; LIFE SATISFACTION; MALE; MALE SEXUAL FUNCTION; MARRIAGE; PARAMETERS; PENIS ERECTION; PREVALENCE; PRIORITY JOURNAL; PROLONGED EJACULATION LATENCY TIME; QUESTIONNAIRE; SEXUAL BEHAVIOR; SEXUAL DESIRE; SEXUAL FUNCTION; SEXUAL SATISFACTION; SMOKING; CHEMICALLY INDUCED; COITUS; DRUG EFFECTS; LIBIDO; MIDDLE AGED; ORGASM; PSYCHOLOGY; SUBSTANCE-RELATED DISORDERS; TAIWAN;

ADULT; AMPHETAMINE; APHRODISIACS; COITUS; CROSS-SECTIONAL STUDIES; ERECTILE DYSFUNCTION; HUMANS; LIBIDO; MALE; MIDDLE AGED; ORGASM; PREVALENCE; SEXUAL BEHAVIOR; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; SURVEYS AND QUESTIONNAIRES; TAIWAN;

EID: 84939568985     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/jsm.12926     Document Type: Article

References (32)

1. Sulzer D, Sonders MS, Poulsen NW, Galli A. Mechanisms of neurotransmitter release by amphetamines: A review. Prog Neurobiol 2005;75:406-433.
2. United Nations Office on Drugs and Crime. Amphetamine-type stimulants: Overview. World Drug Report 2014. United Nations Office on Drugs and Crime, New York, pp. 46-51. 2014.
3. McKetin R, Kelly E, McLaren J. The relationship between crystalline methamphetamine use and methamphetamine dependence. Drug Alcohol Depend 2006;85:198-204.
4. Ciccarone D. Stimulant abuse: Pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy. Prim Care 2011;38:41-58.
5. Hando J, Hall W. HIV risk-taking behaviour among amphetamine users in Sydney, Australia. Addiction 1994;89:79-85.
6. Skårner A, Svensson B. Amphetamine use and sexual practices. Nordic Stud Alcohol Drugs 2013;30:403-423.
7. Pfzus JG, Wilkins MF, DiPietro N, Benibgui M, Toledano R, Rowe A, Couch MC. Inhibitory and disinhibitory effects of psychomotor stimulants and depressants on the sexual behavior of male and female rats. Horm Behav 2010;58:163-176.
8. Frohmader KS, Bateman KL, Lehman MN, Coolen LM. Effects of methamphetamine on sexual performance and compulsive sex behavior in male rats. Psychopharmacology (Berl) 2010;212:93-104.
9. Tar MT, Martinez LR, Nosanchuk JD, Davies KP. The effect of methamphetamine on an animal model of erectile function. Andrology 2014;2:531-536.
10. Peugh J, Belenko S. Alcohol, drugs and sexual function: A review. J Psychoactive Drugs 2001;33:223-232.
11. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The International Index of Erectile Function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 1997;49:822-830.
12. Jiann BP, Su CC, Tsai JY. Is female sexual function related to the male partners' erectile function? J Sex Med 2013;10:420-429.
13. Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH. Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology 1999;54:346-351.
14. Jiann BP. Using the International Index of Erectile Function-5 to assess erectile function in epidemiological studies. J Sex Med 2012;9:327.
15. Lewis RW, Fuel-Meyer KS, Bosch R, Fugl-Meyer AR, Laumann EO, Lizza E, Martin-Morales A. Definitions, classification, and epidemiology of sexual dysfunction. Chapter 2. In: Lue TF, Basson R, Rosen R, Guiliano F, Khoury S, Montorsi F, eds. Sexual dysfunction. Paris: Health Publications Fr.; 2004:39-72.
16. Elbendary MA, El-Gamal OM, Salem KA. Analysis of risk factors for organic erectile dysfunction in Egyptian patients under the age of 40 years. J Androl 2009;30:520-524.
17. Fleckenstein AE, Volz TJ, Riddle EL, Gibb JW, Hanson GR. New insights into the mechanism of action of amphetamines. Annu Rev Pharmacol Toxicol 2007;47:681-698.
18. Uitti RJ, Tanner CM, Rajput AH, Goetz CG, Klawans HL, Thiessen B. Hypersexuality with antiparkinsonism therapy. Clin Neuropharmacol 1989;12:375-383.
19. Adachi H, Sato Y, Kato R, Hisasue S, Suzuki K, Masumori N, Iton N, Tsukamoto T. Direct evidence of facilitative actions of dopamine in the medial preoptic area on reflexive and noncontact erections in male rats. J Urol 2003;169:386-389.
20. Napoli-Farris L, Fratta W, Gessa GL. Stimulation of dopamine autoreceptors elicits "premature ejaculation" in rats. Pharmacol Biochem Behav 1984;20:69-72.
21. Montejo-Gonzalez AL, Llorca G, Izquierdo JA, Ledesma A, Bousono M, Calcedo A, Carrasco JL, Ciudad J, Daniel E, De la Gandara J, Derecho J, Franco M, Gomez MJ, Macias JA, Martin T, Perez V, Sanchez JM, Sanchez S, Vicens E. SSRI-Induced sexual dysfunction: Fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J Sex Marital Ther 1997;23:176-194.
22. Holmes GM, Bresnahan JC, Beattie MS. Inhibition of pudendal reflexes in spinal rats. Reassessing the role of serotonin. Physiol Behav 2001;74:57-64.
23. Ahlenius S, Larsson K, Svensson L, Hjorth S, Carisson A, Lindberg P, Wikström H, Sanchez D, Arvidsson LE, Hacksell U, Nilsson JL. Effects of a new type of 5-HT receptor agonist on male rat sexual behavior. Pharmacol Biochem Behav 1981;15:785-792.
24. Ellison G, Eison MS, Huberman HS, Daniel F. Long-term changes in dopaminergic innervation of caudate nucleus after continuous amphetamine administration. Science 1978;201:276-278.
25. Chen PI, Perez-Martinez S, Cao A, Rhodes CJ, Wang L, Rabinovitch M. Amphetamine induces pulmonary arterial endothelial cell dysfunction by increasing vulnerability to apoptosis and production of pro-inflammatory cytokines. Am J Respir Crit Care Med 2013;187:A1747.
26. Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, Gifford A, Hitzemann R, Ding YS, Pappas N. Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D2 receptor levels. Am J Psychiatry 1999;156:1440-1443.
27. Bell DS, Trethowan WH. Amphetamine addiction and disturbed sexuality. Arch Gen Psychiatry 1961;4:74-78.
28. Macleod J, Oakes R, Copello A, Crome I, Egger M, Hickman M, Oppenkowski T, Stokes-Lampard H, Smith GD. Psychological and social sequelae of cannabis and other illicit drug use by young people: A systematic review of longitudinal, general population studies. Lancet 2004;363:1579-1588.
29. Bang-Ping J. Sexual dysfunction in men who abuse illicit drugs: A preliminary report. J Sex Med 2009;6:1072-1080.
30. Comer SD, Hart CL, Ward AS, Haney M, Foltin RW, Fischman MW. Effects of repeated oral methamphetamine administration in humans. Psychopharmacology (Berl) 2001;155:397-404.
31. Hart CL, Gunderson EW, Perez A, Kirkpatrick MG, Thurmond A, Comer SD, Foltin RW. Acute physiological and behavioral effects of intranasal methamphetamine in humans. Neuropsychopharmacology 2008;33:1847-1855.
32. Ellinwood EH Jr, Lee TH. Dose- and time dependent effect of stimulants. NIDA Res Monogr 1989;94:323-340.